CoChat

The Expression of Osteoprotegerin and RANK Ligand and the Support of Osteoclast Formation by Stromal-Osteoblast Lineage Cells Is Developmentally Regulated

F. Gori · 2000 · Endocrinology
Cited by 73

The DOI matches its OpenAlex record.

Abstract

The one or more molecular mechanisms that determine the obligatory sequence of resorption followed by formation during bone remodeling is unclear. RANK ligand (RANK-L) is an essential requirement for osteoclastogenesis, and its activity is neutralized by binding to the soluble decoy receptor, osteoprotegerin (OPG). Because both molecules are produced by osteoblast lineage cells, we studied their developmental regulation in a conditionally immortalized human marrow stromal (hMS[2–15]) cell line. These cells can simulate the complete developmental sequence from undifferentiated precursor(s) to cells with the complete osteoblast phenotype that are capable of forming mineralized nodules. During osteoblast differentiation, RANK-L messenger RNA levels decreased by 5-fold, whereas OPG messenger RNA levels increased by 7-fold, resulting in a 35-fold change in the RANK-L/OPG ratio. OPG protein also increased by 6-fold. Mouse bone marrow cells generated osteoclast-like cells in coculture with undifferentiated hMS(2–15) cells, but did not when cocultured with hMS(2–15) cells in varying stages of differentiation, unless an excess of RANK-L was added. Thus, undifferentiated marrow stromal cells with a high RANK-L/OPG ratio can initiate and support osteoclastogenesis, but after differentiation to the mature osteoblast phenotype, they cannot. We speculate that the developmental regulation of OPG and RANK-L production by stromal/osteoblast cells contributes to the coordinated sequence of osteoclast and osteoblast differentiation during the bone remodeling cycle.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.1210/en.141.12.4768

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 44

  1. Parfitt, 1994, Osteonal and hemi-osteonal remodeling: the spiral and temporal framework for signal traffic in adult human bone., J Cell Biochem, 55, 273, 10.1002/jcb.240550303 · DOI · Paper page
  2. Suda, 1992, Modulation of osteoclast differentiation., Endocr Rev, 13, 66
  3. Roodman, 1994, Advances in bone biology: the osteoclast., Endocr Rev, 17, 308
  4. Howard, 1981, Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism., Proc Natl Acad Sci USA, 78, 3204, 10.1073/pnas.78.5.3204 · DOI · Paper page
  5. Bonewald, 1990, Role of transforming growth factor-β in bone remodeling., Clin Orthop, 250, 261, 10.1097/00003086-199001000-00036 · DOI · Paper page
  6. Takahashi, 1988, Osteoblastic cells are involved in osteoclast formation., Endocrinology, 123, 2600, 10.1210/endo-123-5-2600 · DOI · Paper page
  7. Jilka, 1996, Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence., J Clin Invest, 97, 1732, 10.1172/JCI118600 · DOI · Paper page
  8. Ducy, 1999, A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development., Genes Dev, 13, 1025, 10.1101/gad.13.8.1025 · DOI · Paper page
  9. Ducy, 1997, Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation., Cell, 89, 747, 10.1016/S0092-8674(00)80257-3 · DOI · Paper page
  10. Komori, 1997, Targeted disruption of cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts., Cell, 89, 755, 10.1016/S0092-8674(00)80258-5 · DOI · Paper page
  11. Otto, 1997, Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development., Cell, 89, 765, 10.1016/S0092-8674(00)80259-7 · DOI · Paper page
  12. Weinstein, 1997, The effect of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage., Endocrinology, 138, 4013, 10.1210/endo.138.9.5359 · DOI · Paper page
  13. Lacey, 1998, Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation., Cell, 93, 165, 10.1016/S0092-8674(00)81569-X · DOI · Paper page
  14. Simonet, 1997, Osteoprotegerin: a novel secreted protein involved in the regulation of bone density., Cell, 89, 309, 10.1016/S0092-8674(00)80209-3 · DOI · Paper page
  15. Yasuda, 1998, Identity of osteoclastogenesis factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro., Endocrinology, 39, 1329, 10.1210/endo.139.3.5837 · DOI · Paper page
  16. Tan, 1997, Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic cells., Gene, 204, 35, 10.1016/S0378-1119(97)00509-X · DOI · Paper page
  17. Bucay, 1998, Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification., Gene Dev, 12, 1260, 10.1101/gad.12.9.1260 · DOI · Paper page
  18. Mizuno, 1998, Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin., Biochem Biophys Res Commun, 247, 610, 10.1006/bbrc.1998.8697 · DOI · Paper page
  19. Burgess, 1999, The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts., J Cell Biol, 145, 527, 10.1083/jcb.145.3.527 · DOI · Paper page
  20. Nakagawa, 1998, RANK is the essential signaling receptor of osteoclast differentiation factor in osteoclastogenesis., Biochem Biophys Res Commun, 253, 395, 10.1006/bbrc.1998.9788 · DOI · Paper page
  21. Anderson, 1997, A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function., Nature, 390, 175, 10.1038/36593 · DOI · Paper page
  22. Hsu, 1999, Tumor necrosis receptor family member RANK mediated osteoclast differentiation and activation induced by osteoprotegerin ligand., Proc Natl Acad Sci USA, 96, 3540, 10.1073/pnas.96.7.3540 · DOI · Paper page
  23. Quinn, 1998, A combination of osteoclast differentiation factor and macrophages-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro., Endocrinology, 139, 4424, 10.1210/endo.139.10.6331 · DOI · Paper page
  24. Hicok, 1998, Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma., J Bone Miner Res, 13, 205, 10.1359/jbmr.1998.13.2.205 · DOI
  25. Gori, 1999, Differentiation of human marrow stromal cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment and inhibits late adipocyte maturation., J Bone Miner Res, 14, 1522, 10.1359/jbmr.1999.14.9.1522 · DOI · Paper page
  26. Hofbauer, 1999, Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanism of glucocorticoid-induced osteoporosis., Endocrinology, 140, 4382, 10.1210/endo.140.10.7034 · DOI · Paper page
  27. Puzas, 1985, Bone cell phosphotyrosine phosphate: characterization and regulation by calcitropic hormones., Endocrinology, 116, 2463, 10.1210/endo-116-6-2463 · doi:10.1210/endo-116-6-2463
  28. Bodine, 1996, Development and characterization of a conditionally transformed adult human osteoblastic cell line., J Bone Miner Res, 11, 806, 10.1002/jbmr.5650110612 · DOI
  29. Lehrach, 1997, RNA molecular weight determination by gel electrophoresis under denaturating conditions, a critical reexamination., Biochem Cell, 89, 747
  30. Thomas, 1980, Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulosa., Proc Natl Acad Sci USA, 77, 5201, 10.1073/pnas.77.9.5201 · DOI · Paper page
  31. Feinberg, 1983, A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity., Anal Biochem, 132, 6, 10.1016/0003-2697(83)90418-9 · DOI · Paper page
  32. Hofbauer, 1998, Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2 and cytokines., Biochem Biophys Res Commun, 250, 776, 10.1006/bbrc.1998.9394 · DOI · Paper page
  33. Cheng, 1994, Differentiation of human bone marrow osteogenic stromal cells in vitro. Induction of the osteoblast phenotype by dexamethasone., Endocrinology, 134, 277, 10.1210/endo.134.1.8275945 · doi:10.1210/endo.134.1.8275945 · Paper page
  34. Grigoriadis, 1988, Differentiation of muscle, fat, cartilage and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone., J Cell Biol, 106, 2139, 10.1083/jcb.106.6.2139 · DOI · Paper page
  35. Locklin, 1995, In vitro effects of growth factors and dexamethasone on rat marrow stromal cells., Clin Orthop, 313, 27
  36. Rickard, 1994, Induction of rapid osteoblast differentiation in rat bone marrow stromal cell culture by dexamethasone and BMP-2., Dev Biol, 12, 871
  37. Franceschi, 1992, The role of ascorbic acid in mesenchymal differentiation., Nutr Rev, 50, 65, 10.1111/j.1753-4887.1992.tb01271.x · DOI · Paper page
  38. Nagai, 1999, Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation., Biochem Biophys Res Commun, 257, 719, 10.1006/bbrc.1999.0524 · DOI · Paper page
  39. Kitazawa, 1999, Promotor structure of mouse RANKL/TRANCE/OPGL/ODF gene., Biochim Biophys Acta, 1445, 134, 10.1016/S0167-4781(99)00032-9 · DOI
  40. Romas, 1997, Cytokines in the pathogenesis of osteoporosis, Osteoporos Int, 7, S47, 10.1007/BF03194342 · DOI
  41. Adebanjo, 1998, Mode of action of interleukin-6 on mature osteoclasts. Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption., J Cell Biol, 142, 1347, 10.1083/jcb.142.5.1347 · DOI
  42. Fuller, 1998, TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts., J Exp Med, 188, 997, 10.1084/jem.188.5.997 · DOI · Paper page
  43. Weng, 2000, The monoclonal antibodies 18d7/91f2 recognize a receptor regulatory protein on mouse bone marrow stromal cells., J Bone Miner Res, 15, 1286, 10.1359/jbmr.2000.15.7.1286 · doi:10.1359/jbmr.2000.15.7.1286
  44. Hughes, 1996, Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β., Nat Med, 2, 1132, 10.1038/nm1096-1132 · DOI · Paper page

Cited by

See all 73

Metadata

Authors
Gori, F.
Venue
Endocrinology
Published
2000-12-01
Volume
141
Issue
12
Pages
4768-4776
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W4245062444
Cited by
73
References
0
FWCI
0.79
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Expression of Osteoprotegerin and RANK Ligand and the Support of Osteoclast Formation by Stromal-Osteoblast Lineage Cells Is Developmentally Regulated. https://app.cochat.ai/papers/10.1210/en.141.12.4768
The paper
Gori, F. (2000). The Expression of Osteoprotegerin and RANK Ligand and the Support of Osteoclast Formation by Stromal-Osteoblast Lineage Cells Is Developmentally Regulated. Endocrinology. https://doi.org/10.1210/en.141.12.4768

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.